Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

Weight loss drugs are in high demand, but most employers can’t shoulder the cost as health care rates skyrocket.

In other news, Lilly announced its investigational oral GLP-1 agent orforglipron outperformed dapagliflozin (Farxiga) for ...

Ensuring GLP-1s are covered by Medicaid in all states would save lives—and not be as costly as some people fear.

Denmark's Novo Nordisk, the pharmaceutical giant behind blockbuster drugs Ozempic and Wegovy, is set for a major boardroom ...

Denmark's Novo Nordisk said Tuesday it would replace more than half of its board, including the chair, as the Ozempic and ...

A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives ...

Unlike some other call centres run by banks, telecommunications companies and airlines, the CRA does not always offer a call ...

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...